%0
Generic
%T
Final results of AGITG ATTAX3 study: Randomized phase II study of weekly docetaxel (T), cisplatin, and fluoropyrimidine (F) with or without panitumumab (P) in advanced esophagogastric (OG) cancer.
%A Tebbutt, Niall C.
%A Price, Timothy Jay
%A Sjoquist, Katrin Marie
%A Veillard, Anne-Sophie
%A Hall, Merryn
%A Ferraro, Danielle Angela
%A Wong, Nicole
%A Pavlakis, Nick
%A Strickland, Andrew
%A Varma, Suresh Chandra
%A Cooray, Prasad
%A Young, Rosemary
%A Underhill, Craig
%A Shannon, Jennifer Anne
%A Ganju, Vinod
%A Gebski, Val
%I American Society of Clinical Oncology (ASCO)
%@ 0732-183X
%@ 1527-7755
%K Cancer Research
%K Oncology
%D 2013
%C American Society of Clinical Oncology (ASCO)
%U https://katalog.slub-dresden.de/en/?cHash=d436d54d7a76fc6fe03d5b8c85ebf4cf&tx_find_find%5Baction%5D=citation&tx_find_find%5Bcontroller%5D=Search&tx_find_find%5Bid%5D=ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTIwMC9qY28uMjAxMy4zMS4xNV9zdXBwbC40MDgx&tx_find_find%5Btype%5D=endnote